280E Tax Relief Won’t Fix Everything. Here’s What Cannabis Lenders Still Fear
In the second installment of IgniteIt’s exclusive interview series with Terrance “Terry” Mendez, CEO of Safe Harbor Financial, we explored a question that extends well beyond the future of any single company: Will relief from Section 280E finally make cannabis businesses more profitable and easier to finance?
The conversation followed five interconnected questions: what Washington might deliver following the midterm elections, how federal tax relief could change operators’ finances, whether state-level regulations might offset those benefits, what lenders need to see before committing capital, and whether cannabis can eventually operate under financial rules comparable to those governing other consumer products industries.
For Mendez, the answer begins with a distinction between regulatory progress and economic viability.
“I’m hopeful, but at the same time a little cautious, well, very cautious to say, let’s see how they legislate this and let’s see how it comes and is there any profit left for the operator?” Mendez told IgniteIt.
His concern is that removing one financial obstacle does not necessarily resolve the underlying conditions that make cannabis businesses difficult to finance.
280E and the Economics of Legal Cannabis
Section 280E of the Internal Revenue Code has historically prevented cannabis businesses from deducting many ordinary operating expenses, producing tax burdens substantially higher than those faced by conventional companies.
Relief from the provision could improve after-tax cash flow, giving operators more flexibility to repay debt, invest in expansion, and strengthen their financial positions.
But Mendez argues that the industry’s economic disadvantages extend beyond federal taxation.
“Cannabis needs to be treated like any other normal CPG business with manufacturing, distribution, and outlets to consumers,” he said.
“Schedule three is a phenomenal first step. Legalization is the next step hopefully, but at the end of the day, the economics of a cannabis company are going to be influenced by regulatory deformity.”
Mendez pointed to federal taxes, restrictions on interstate commerce and differences among state and local regulatory systems as sources of additional operating costs.
“We’re in a deformed industry from a regulation perspective,” he said.
Legal cannabis companies must absorb those costs while competing against illicit businesses that operate without comparable regulatory obligations.
For lenders evaluating the industry’s financial prospects, that distinction matters. A reduction in federal taxes could improve a borrower’s financial position, but it would not automatically eliminate the structural disadvantages affecting the business.
What Could Washington Deliver After the Midterms?
Asked about the prospects for 280E reform in 2027 and his conversations with policymakers, Mendez declined to predict a specific outcome.
“I’ll give you my perspective as opposed to guessing on decision makers because I do talk to some of them, but ultimately there’s more than one and so you never really know who’s going to win the conflict of debate,” he said.
He believes the Trump administration’s cannabis reform initiatives have changed the political conversation, creating opportunities for additional federal action.
But he also warned that the next phase could involve what he described as political “placation,” with policymakers offering limited reforms rather than addressing the industry’s broader financial challenges.
“You might get something. You might get rescheduling of recreational, right? You might have some kind of alignment as to what that looks like from a federal regulation perspective, but I’m not sure what you get long term.”
Mendez’s comments reflect his assessment of the political environment rather than a forecast of specific legislation.
For cannabis operators, the distinction between tax relief, federal rescheduling and broader legalization remains important. Each could affect the industry’s economics differently, and progress in one area does not necessarily resolve restrictions in another.
The Risk of Regulating an Industry Out of Profitability
Mendez also raised concerns about state-level policies that could undermine the financial benefits of federal reform.
He cited Michigan’s cannabis taxation and the possibility of changes to legalization in Massachusetts as examples of regulatory uncertainty that lenders must consider.
His concern is not simply whether cannabis remains legal, but whether businesses can generate sustainable profits under the rules governing their operations.
“While you might get something, is the something that you got worth the investment?” he asked.
For lenders, uncertainty becomes particularly consequential when financing assets expected to generate returns over many years.
Mendez discussed the difficulty of evaluating long-term loans when a state’s regulatory framework could change before the borrower finishes repaying the debt.
The possibility of additional taxes, new restrictions or changes to legalization can complicate underwriting even when an operator’s current financial performance appears sound.
That creates a fundamental challenge for cannabis finance: lenders must assess not only whether a business can repay a loan today, but whether the market in which it operates will remain viable throughout the financing period.
Mendez’s conclusion was cautious.
“Let’s see how they legislate this and let’s see how it comes and is there any profit left for the operator?”
Could Eliminating 280E Improve Access to Credit?
During the interview, IgniteIt asked Mendez whether relief from 280E could increase loan repayment rates, encourage additional borrowing or free up more cash for debt service.
He did not provide a specific forecast.
Instead, he explained the relationship between the financial health of cannabis operators and the institutions that serve them.
“Everything about Safe Harbor is designed to win when our customers, the banks and our clients, the operators win,” Mendez said.
“If client deposits are going up, we’re going to make some more money. Right? If lending opportunities increase and we can participate in those, we’ll make some more money.”
The broader implication is that improved after-tax cash flow could make some operators more attractive borrowers.
Additional liquidity may strengthen their ability to meet existing obligations, finance expansion or maintain larger deposits.
But the effect would depend on each company’s financial position, debt burden and operating environment.
Mendez emphasized that cannabis lending remains difficult even for financial institutions already willing to serve the industry.
He estimated that approximately 4,000 financial institutions could potentially participate in cannabis banking, but only 200 to 250 actively pursue cannabis deposits.
Of that smaller group, he estimated that just 10% to 20% actively provide loans.
Those figures are his industry estimates, not independently verified totals.
“Access to capital is hard,” Mendez said.
“And why is that? It’s because it’s really hard to read a P&L or a balance sheet and forecast that out and go through normal standardized underwriting of a financial institution.”
Unlike conventional businesses operating under relatively consistent financial rules, cannabis companies face regulatory differences across jurisdictions that complicate revenue forecasts, expense projections and assessments of long-term risk.
Mendez summarized the problem with an analogy.
“They just want to add volume into a pipe. For cannabis, you got to build a whole new pipe. And every year in every jurisdiction, that pipe’s a little different.”
What Would Make Cannabis a Normal Lending Market?
For Mendez, federal banking legislation remains an important part of the industry’s financial future.
He identified measures such as the SAFER Banking Act, the STATES Act, the CLIMB Act and the PREPARE Act as examples of proposals that could help address different aspects of the industry’s legal and financial challenges.
He also emphasized the importance of aligning federal cannabis policy with the practical realities of state-regulated markets.
The underlying objective is to reduce the uncertainty that makes cannabis lending more complicated than financing comparable businesses in other industries.
Conventional lenders evaluate borrowers through financial statements, projected cash flows, collateral and the likelihood of repayment.
Cannabis lenders must consider those factors alongside federal restrictions, state-specific licensing rules, potential tax changes and the possibility that future legislation could alter a borrower’s market.
Removing 280E could improve one part of that calculation, but it would not eliminate the other risks.
The potential benefits of reform therefore extend beyond immediate tax savings. A more predictable regulatory environment could help lenders evaluate cannabis companies using financial assumptions closer to those applied elsewhere in the economy.
For Mendez, however, that outcome remains dependent on how policymakers design and implement future reforms.
His central concern is whether the next phase of cannabis policy will genuinely improve the industry’s economics or simply replace existing obstacles with new ones.
“While you might get something, is the something that you got worth the investment?”

